Macrolide-Resistant Mycoplasma pneumoniae, United States

Emerg Infect Dis. 2015 Aug;21(8):1470-2. doi: 10.3201/eid2108.150273.

Abstract

Macrolide-resistant Mycoplasma pneumoniae (MRMP) is highly prevalent in Asia and is now being reported from Europe. Few data on MRMP are available in the United States. Using genotypic and phenotypic methods, we detected high-level MRMP in 13.2% of 91 M. pneumoniae--positive specimens from 6 US locations.

Keywords: MIC; Mycoplasma pneumoniae; United States; antimicrobial resistance; bacteria; children; macrolide.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Child, Preschool
  • Drug Resistance, Bacterial / drug effects*
  • Drug Resistance, Bacterial / genetics
  • Humans
  • Infant
  • Macrolides / therapeutic use*
  • Microbial Sensitivity Tests / statistics & numerical data*
  • Middle Aged
  • Mycoplasma pneumoniae / drug effects*
  • Mycoplasma pneumoniae / genetics
  • Mycoplasma pneumoniae / immunology
  • Pneumonia, Mycoplasma / epidemiology*
  • United States / epidemiology

Substances

  • Anti-Bacterial Agents
  • Macrolides